This finding suggests that KRE feeding inhibited LSD1 activity, leading to the anti-proliferative effects of KRE on prostate tumor tissues of mouse models and therefore delaying the progression of prostate cancer. The gene discussed is KDM1A; the disease is prostate carcinoma.